Evidence map›Paper›PMID 33911214›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2021

The genetic landscape of intellectual disability and epilepsy in adults and the elderly: a systematic genetic work-up of 150 individuals.

Pia Zacher, Thomas Mayer, Frank Brandhoff, Tobias Bartolomaeus, Diana Le Duc, Martin Finzel, Anja Heinze, Susanne Horn, Chiara Klöckner, Gudrun Körber and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Genetic Diagnosis in Epilepsy: Implications for Clinical Management.Current neurology and neuroscience reports · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Further advances in epilepsy.Journal of neurology · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Epilepsy and genetics.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2022
    Article
  20. Monogenetic epilepsies and how to approach them in 2022.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Pia ZacherEpilepsy Center Kleinwachau, Radeberg, Germany. p.zacher@kleinwachau.de.
Thomas MayerEpilepsy Center Kleinwachau, Radeberg, Germany.
Frank BrandhoffEpilepsy Center Kleinwachau, Radeberg, Germany.
Tobias BartolomaeusInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Diana Le DucInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Martin FinzelEpilepsy Center Kleinwachau, Radeberg, Germany.
Anja HeinzeInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Susanne HornInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Chiara KlöcknerInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Gudrun KörberEpilepsy Center Kleinwachau, Radeberg, Germany.
Julia HentschelInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Malgorzata KalitaEpilepsy Center Kleinwachau, Radeberg, Germany.
Ilona KreyInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Marina Nastainczyk-WulfInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Konrad PlatzerInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Johannes RebstockEpilepsy Center Kleinwachau, Radeberg, Germany.
Bernt PoppInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Mathias StillerInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Anne-Christin TeichmannInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Rami Abou JamraInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Johannes R LemkeInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany. Johannes.Lemke@medizin.uni-leipzig.de.ORCID 0000-0002-4435-6610
Leipzig University · DEEpilepsiezentrum Kleinwachau Gemeinnützige · DEPraxis für Humangenetik Tübingen · DEUniversity Hospital in Halle · DEUniversity Hospital Leipzig · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGenetic diagnostics of neurodevelopmental disorders with epilepsy (NDDE) are predominantly applied in children, thus limited information is available regarding adults or elderly.

methodsWe investigated 150 adult/elderly individuals with NDDE by conventional karyotyping, FMR1 testing, chromosomal microarray, panel sequencing, and for unresolved cases, also by exome sequencing (n

resultsWe identified (likely) pathogenic variants in 71 cases (47.3%) comprising fragile X syndrome (n = 1), disease-causing copy number (n = 23), and single-nucleotide variants (n = 49). Seven individuals displayed multiple independent genetic diagnoses. The diagnostic yield correlated with the severity of intellectual disability. Individuals with anecdotal evidence of exogenic early-life events (e.g., nuchal cord, complications at delivery) with alleged/unproven association to the disorder had a particularly high yield of 58.3%. Screening for disease-specific comorbidities was indicated in 45.1% and direct treatment consequences arose in 11.8% of diagnosed individuals.

conclusionPanel/exome sequencing displayed the highest yield and should be considered as first-tier diagnostics in NDDE. This high yield and the numerous indications for additional screening or treatment modifications arising from genetic diagnoses indicate a current medical undersupply of genetically undiagnosed adult/elderly individuals with NDDE. Moreover, knowledge of the course of elderly individuals will ultimately help in counseling newly diagnosed individuals with NDDE.

Indexed as

EpilepsyIntellectual DisabilityNeurodevelopmental DisordersAdultAgedExome SequencingFragile X Messenger Ribonucleoprotein 1HumansKaryotypingFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID33911214
PMCPMC8354852
OpenAlexW3158806318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.